Kezar Life Sciences Inc. (KZR)
NASDAQ: KZR
· Real-Time Price · USD
3.97
-0.01 (-0.25%)
At close: Aug 15, 2025, 3:59 PM
4.07
2.52%
After-hours: Aug 15, 2025, 07:48 PM EDT
Kezar Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | -5.43M | 1.57M | 1.57M | 1.57M | 7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 511K | 772K | 781K | 1.06M | 1.08M | 1.07M | 1.07M | 13.79M | 13.97M | 14.15M | 14.31M | 1.69M | 1.61M | 1.55M | 1.51M | 1.12M | 745K | 372K |
Gross Profit | 10K | -251K | -260K | -1.06M | 5.92M | 5.93M | 5.93M | -6.79M | -13.97M | -14.15M | -14.31M | -1.69M | -1.61M | -1.55M | -1.51M | -1.12M | -745K | -372K |
Operating Income | -75.74M | -84.52M | -90.61M | -97.44M | -101.02M | -104.42M | -105.24M | -96.87M | -90.27M | -79.81M | -71.16M | -65.23M | -60.8M | -57.49M | -54.66M | -51.62M | -48.68M | -45.52M |
Interest Income | 6.39M | 7.43M | 8.46M | 9.46M | 10.24M | 10.86M | 11.1M | 10.58M | 9.15M | 6.7M | 4.11M | 1.96M | 603K | 242K | 188K | 265K | 490K | 796K |
Pretax Income | -70.79M | -78.63M | -83.74M | -95.78M | -98.57M | -101.33M | -101.87M | -87.79M | -82.53M | -74.41M | -68.24M | -64.27M | -60.88M | -57.66M | -54.63M | -51.36M | -48.19M | -44.72M |
Net Income | -70.79M | -78.63M | -83.74M | -95.78M | -98.57M | -101.33M | -99.92M | -83.98M | -77.65M | -69.53M | -65.45M | -63.34M | -61.03M | -57.81M | -54.63M | -51.36M | -48.19M | -44.72M |
Selling & General & Admin | 21.72M | 22.04M | 22.87M | 22.81M | 25.89M | 26.33M | 26.26M | 25.95M | 22.23M | 21.43M | 20.15M | 19.3M | 18.2M | 16.9M | 15.72M | 14.35M | 13.67M | 12.71M |
Research & Development | 54.03M | 60.75M | 65.74M | 72.35M | 79.85M | 84.55M | 85.7M | 67.91M | 58.04M | 48.38M | 41.01M | 45.93M | 42.6M | 40.59M | 38.94M | 37.27M | 35M | 32.81M |
Other Expenses | -12K | -12K | -12K | n/a | -278K | -278K | -278K | 9.72M | 10M | 10M | 10M | 1K | 1K | 1K | 1K | n/a | n/a | n/a |
Operating Expenses | 75.74M | 82.78M | 88.6M | 95.16M | 105.46M | 110.61M | 111.68M | 103.59M | 90.27M | 79.81M | 71.16M | 65.23M | 60.8M | 57.49M | 54.66M | 51.62M | 48.68M | 45.52M |
Interest Expense | 1.44M | 1.54M | 1.59M | 1.6M | 1.6M | 1.58M | 1.55M | 1.5M | 1.41M | 1.3M | 1.19M | 995K | 685K | 413K | 159K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -261K | -521K | -801K | -801K | -540K | -280K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 75.74M | 84.52M | 90.61M | 103.63M | 114.21M | 117.61M | 118.42M | 103.87M | 90.27M | 79.81M | 71.16M | 65.23M | 60.8M | 57.49M | 54.66M | 51.62M | 48.68M | 45.52M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.96M | -3.81M | -4.89M | -4.89M | -2.79M | -934K | 38K | 38K | -108K | -108K | n/a | n/a |
Shares Outstanding (Basic) | 7.31M | 7.31M | 7.3M | 72.96M | 72.88M | 72.8M | 72.74M | 72.68M | 72.46M | 72.33M | 72.23M | 72.15M | 64.28M | 60.63M | 55.98M | 52.05M | 51.9M | 51.06M |
Shares Outstanding (Diluted) | 7.31M | 7.31M | 7.3M | 72.96M | 72.88M | 72.8M | 72.74M | 72.68M | 72.46M | 72.33M | 72.23M | 72.15M | 64.28M | 60.63M | 55.98M | 52.05M | 51.9M | 51.06M |
EPS (Basic) | -7.19 | -5.62 | -3.65 | -1.32 | -1.36 | -1.4 | -1.38 | -1.17 | -1.08 | -0.99 | -0.98 | -1 | -1.05 | -1.05 | -1.03 | -1 | -0.95 | -0.92 |
EPS (Diluted) | -7.19 | -5.62 | -3.65 | -1.32 | -1.36 | -1.4 | -1.38 | -1.17 | -1.08 | -0.99 | -0.98 | -1 | -1.05 | -1.05 | -1.03 | -1 | -0.95 | -0.92 |
EBITDA | -69.78M | -76.06M | -81.1M | -93.11M | -95.89M | -98.68M | -99.33M | -85.58M | -80.23M | -72.04M | -65.83M | -61.4M | -58.44M | -55.55M | -52.74M | -50.03M | -47.02M | -43.91M |
EBIT | -69.35M | -77.09M | -82.14M | -94.17M | -96.97M | -99.75M | -100.32M | -86.29M | -81.12M | -73.11M | -67.05M | -63.14M | -60.06M | -57.11M | -54.33M | -51.49M | -48.58M | -45.47M |
Depreciation & Amortization | 770K | 1.03M | 1.04M | 1.06M | 1.08M | 1.07M | 1.07M | 503K | 683K | 865K | 1.02M | 1.69M | 1.61M | 1.55M | 1.51M | 1.49M | 1.56M | 1.55M |